ArticleMolecular neurodegeneration2018

Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation.

Changyoun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.